| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |